Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Samuel Kakraba

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
Frontiers in Public Health|April 13, 2026
Cognitive sovereignty and decolonial public health: reclaiming epistemic authority in the global AI eraSamuel Kakraba, Edmund Fosu Agyemang, Sudesh K Srivastav
JMIR AI|December 8, 2025
Accelerating Discovery of Leukemia Inhibitors with AI-Driven QSAR ModelingSamuel Kakraba, Edmund Fosu Agyemang, Robert J Shmookler Reis
JMIR Aging|December 30, 2025
Artificial Intelligence-Enhanced Multi-Algorithm R Shiny Application for Predictive Modeling and Analytics: Case Study of Alzheimer Disease DiagnosticsHan Wenzheng, Edmund F Agyemang, Sudesh K Srivastav, et al.
Acta Psychologica|May 23, 2026
Leveraging machine learning algorithms and explainable AI for predicting mental health disorder treatment at the workplaceDaniela Candanedo, Edmund Agyemang, Farhana Chaudhry, et al.
Antioxidants & Redox Signaling|May 25, 2017
Aspirin-Mediated Acetylation Protects Against Multiple Neurodegenerative Pathologies by Impeding Protein AggregationSrinivas Ayyadevara, Meenakshisundaram Balasubramaniam, Samuel Kakraba, et al.
JMIR AI|December 4, 2025
Machine Learning-Enhanced Quantitative Structure-Activity Relationship Modeling for DNA Polymerase Inhibitor Discovery: Algorithm Development and ValidationSamuel Kakraba, Srinivas Ayyadevara, Aayire Yadem Clement, et al.
Molecules (Basel, Switzerland)|August 14, 2020
Design and Synthesis of Novel Hybrid 8-Hydroxy Quinoline-Indole Derivatives as Inhibitors of Aβ Self-Aggregation and Metal Chelation-Induced Aβ AggregationSuresh K Bowroju, Nirjal Mainali, Srinivas Ayyadevara, et al.
Iscience|October 9, 2019
Aggregate Interactome Based on Protein Cross-linking Interfaces Predicts Drug Targets to Limit Aggregation in Neurodegenerative DiseasesMeenakshisundaram Balasubramaniam, Srinivas Ayyadevara, Akshatha Ganne, et al.
Pharmaceuticals (Basel, Switzerland)|October 28, 2023
Thiadiazolidinone (TDZD) Analogs Inhibit Aggregation-Mediated Pathology in Diverse Neurodegeneration Models, and Extend <i>C. elegans</i> Life- and HealthspanSamuel Kakraba, Srinivas Ayyadevara, Nirjal Mainali, et al.
Frontiers in Molecular Neuroscience|January 11, 2020
A Novel Microtubule-Binding Drug Attenuates and Reverses Protein Aggregation in Animal Models of Alzheimer's DiseaseSamuel Kakraba, Srinivas Ayyadevara, Narsimha Reddy Penthala, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Frontiers in Public Health|April 13, 2026
Cognitive sovereignty and decolonial public health: reclaiming epistemic authority in the global AI eraSamuel Kakraba, Edmund Fosu Agyemang, Sudesh K Srivastav
JMIR AI|December 8, 2025
Accelerating Discovery of Leukemia Inhibitors with AI-Driven QSAR ModelingSamuel Kakraba, Edmund Fosu Agyemang, Robert J Shmookler Reis
JMIR Aging|December 30, 2025
Artificial Intelligence-Enhanced Multi-Algorithm R Shiny Application for Predictive Modeling and Analytics: Case Study of Alzheimer Disease DiagnosticsHan Wenzheng, Edmund F Agyemang, Sudesh K Srivastav, et al.
Acta Psychologica|May 23, 2026
Leveraging machine learning algorithms and explainable AI for predicting mental health disorder treatment at the workplaceDaniela Candanedo, Edmund Agyemang, Farhana Chaudhry, et al.
Antioxidants & Redox Signaling|May 25, 2017
Aspirin-Mediated Acetylation Protects Against Multiple Neurodegenerative Pathologies by Impeding Protein AggregationSrinivas Ayyadevara, Meenakshisundaram Balasubramaniam, Samuel Kakraba, et al.
JMIR AI|December 4, 2025
Machine Learning-Enhanced Quantitative Structure-Activity Relationship Modeling for DNA Polymerase Inhibitor Discovery: Algorithm Development and ValidationSamuel Kakraba, Srinivas Ayyadevara, Aayire Yadem Clement, et al.
Molecules (Basel, Switzerland)|August 14, 2020
Design and Synthesis of Novel Hybrid 8-Hydroxy Quinoline-Indole Derivatives as Inhibitors of Aβ Self-Aggregation and Metal Chelation-Induced Aβ AggregationSuresh K Bowroju, Nirjal Mainali, Srinivas Ayyadevara, et al.
Iscience|October 9, 2019
Aggregate Interactome Based on Protein Cross-linking Interfaces Predicts Drug Targets to Limit Aggregation in Neurodegenerative DiseasesMeenakshisundaram Balasubramaniam, Srinivas Ayyadevara, Akshatha Ganne, et al.
Pharmaceuticals (Basel, Switzerland)|October 28, 2023
Thiadiazolidinone (TDZD) Analogs Inhibit Aggregation-Mediated Pathology in Diverse Neurodegeneration Models, and Extend <i>C. elegans</i> Life- and HealthspanSamuel Kakraba, Srinivas Ayyadevara, Nirjal Mainali, et al.
Frontiers in Molecular Neuroscience|January 11, 2020
A Novel Microtubule-Binding Drug Attenuates and Reverses Protein Aggregation in Animal Models of Alzheimer's DiseaseSamuel Kakraba, Srinivas Ayyadevara, Narsimha Reddy Penthala, et al.
Pageof 2